Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
LOOP GENOMICS
Fourth Extension - Granted
Show more
Class 1: Reagents for scientific and research use; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for basic scientific research and for pharmaceutical, industrial, and medical research purposes
Class 5: Reagents for medical or veterinary purposes; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for medical diagnostic purposes
Class 42: DNA and RNA analysis services for scientific research purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for scientific and medical research purposes; software as a service services, namely, providing temporary use of non-downloadable software for bioinformatic analysis of sequencing data
Class 44: DNA and RNA analysis services for medical diagnostic purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application-specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for medical diagnostic purposes
Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaSClass 44 – Medical & beauty services
Status timeline
- 2 Dec 2022Application filedNew Application Entered
- 7 Sep 2023Assigned to an examining attorneyAssigned To Examiner
- 8 Sep 2023Office action issuedNon-Final Action Written
- 2 Nov 2023Response to office action filedTeas Response To Office Action Received
- 6 Nov 2023Approved for publicationApproved For Pub - Principal Register
- 12 Dec 2023Published for oppositionPublished For Opposition
- 6 Feb 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 1 Jul 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 22 Jan 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 4 Aug 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
All 31 events
| 2026-07-31 | Sou Teas Extension Received |
| 2026-02-03 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-02-02 | Sou Teas Extension Received |
| 2026-02-02 | Sou Extension 4 Filed |
| 2026-02-02 | Sou Extension 4 Granted |
| 2025-08-05 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-04 | Sou Teas Extension Received |
| 2025-08-04 | Sou Extension 3 Filed |
| 2025-08-04 | Sou Extension 3 Granted |
| 2025-03-03 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-01-22 | Sou Extension 2 Granted |
| 2025-01-21 | Sou Teas Extension Received |
| 2025-01-21 | Sou Extension 2 Filed |
| 2024-07-01 | Sou Teas Extension Received |
| 2024-07-01 | Sou Extension 1 Filed |
| 2024-07-01 | Sou Extension 1 Granted |
| 2024-07-01 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-02-06 | Noa Mailed - Sou Required From Applicant |
| 2023-12-12 | Published For Opposition |
| 2023-12-12 | Official Gazette Publication Confirmation E-Mailed |
| 2023-11-22 | Notification Of Notice Of Publication E-Mailed |
| 2023-11-06 | Approved For Pub - Principal Register |
| 2023-11-03 | Teas/Email Correspondence Entered |
| 2023-11-02 | Teas Response To Office Action Received |
| 2023-11-02 | Correspondence Received In Law Office |
| 2023-09-08 | Non-Final Action Written |
| 2023-09-08 | Non-Final Action E-Mailed |
| 2023-09-08 | Notification Of Non-Final Action E-Mailed |
| 2023-09-07 | Assigned To Examiner |
| 2022-12-22 | New Application Office Supplied Data Entered |
| 2022-12-02 | New Application Entered |
Goods & services by class
Class 1 Chemicals
Reagents for scientific and research use; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for basic scientific research and for pharmaceutical, industrial, and medical research purposes
Class 5 Pharmaceuticals & supplements
Reagents for medical or veterinary purposes; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for medical diagnostic purposes
Class 42 Technology & SaaS
DNA and RNA analysis services for scientific research purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for scientific and medical research purposes; software as a service services, namely, providing temporary use of non-downloadable software for bioinformatic analysis of sequencing data
Class 44 Medical & beauty services
DNA and RNA analysis services for medical diagnostic purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application-specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for medical diagnostic purposes
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 31 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.